FindTrial
Sign In

Adoptive transfer of CTL induced by peptide-pulsed dendritic cell in patients with advansed GI & HBP cancer

Adoptive transfer of CTL induced by peptide-pulsed dendritic cell in patients with advansed GI & HBP cancer - Peptide-pulsed DC induced CTL therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005821
Enrollment
15
Registered
2011-06-22
Start date
1999-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced GI &amp

Interventions

Transfer of CTL induced by peptide-pulsed dendritic cells in patients with advanced GI &amp
HBP cancer

Sponsors

Tokyo Women's Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Clinically or pathologically diagnosed cancer 2.Age between 20 to 80 3.No severe organ function impairment 4.Patients who have unresectable tumors to be refractory to chemotherapy 5.Written informed consent of the patient 6.Performance Status 0-2

Exclusion criteria

Exclusion criteria: 1.Pregnancy or lactation 2.Decision of unsuitableness by principal investigator 3.Patient with severe underlying disease 4.Patient with severe allergy disease

Design outcomes

Primary

MeasureTime frame
Safety Clinical response—

Secondary

MeasureTime frame
Immunological response—

Countries

Japan

Contacts

Public ContactAtsushi Aruga

Tokyo Women's Medical University Institute of Advanced Biomedial Engineering and Science

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026